Forward P/S Multiple: CONMED (CNMD)

CONMED Corporation - graphic logo of issuer CNMD

The projected P/S ratio correlates with the dynamics of scheduled surgeries and FDA approvals, while 0.60 captures the magnitude of this parameter for CONMED Corporation (CNMD). The development of electrosurgical systems and implants ensures a steady influx of profitable devices. Business resilience is sustained by the synergy between talented engineers and motivated sales managers who receive high bonuses for equipment sales.

conmed.com - CNMD Market Cap to Projected Revenue (period 07/04/2022 - 11/16/2026)

Summary analytical data breakdowns for CONMED Corporation (CNMD)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:CNMD (CONMED Corp.)
Product sample of CONMED Inc.

CONMED Corporation generates a steady cash flow driven by widespread demand for disposable surgical consumables. The current forward P/S ratio compares market capitalization with expected revenue, determining the degree of optimism currently priced in. The trend of this metric helps identify unjustified premiums for business scalability. An analysis of the trajectory confirms the extent to which the current asset value aligns with the company's actual expansion rates.

Who CONMED Corporation competes with

Price-to-Projected Revenue Ratio Dexcom CGM DXCM|Penumbra Corp (PEN) - Market Cap to Future Revenue Ratio|Novanta Inc - Forward P/S Multiple|HAE (Haemonetics Corporation) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|PLSE (Pulse Medical) - Forward P/S Multiple|InMode Corp (INMD) - Market Cap to Expected Sales Ratio|Forward P/S Multiple PMI|Forward Price-to-Revenue Multiple Surmodics, Inc. SRDX|Forward P/S Multiple SENS (senseonics.com)|Forward P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Projected Revenue Ratio|SNWV: Price-to-Projected Revenue Ratio|Outset Medical Corp (OM) - Price-to-Projected Revenue Ratio|SmartVest - Forward Price to Sales|LNSR (LENSAR Inc) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AVITA Medical Inc. RCEL|Price-to-Projected Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Projected Price to Revenue|EDAP TMS SA - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx LUNG|TELA Bio (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corp.)|Price-to-Projected Revenue Ratio sensushealthcare.com|Forward Price-to-Revenue Multiple Zynex, Inc. (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio inspira-technologies.com IINN|Price to Expected Revenue Ratio ICU (SeaStar Medical Holding Corp.)|IRIX: Forward Price-to-Revenue Multiple|ibs.inc - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Future Price to Revenue PFSA (Profusa Inc.)|Forward Price-to-Revenue Multiple SSKN|Price-to-Projected Revenue Ratio GCTK|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|Venus Concept - Market Cap to Projected Revenue|Forward P/S Multiple NUWE (Nuwellis Corp)|Forward Price to Sales AEMD|ASXC - Price-to-Projected Revenue Ratio|Projected Price to Revenue Avinger, Inc (AVGR)|BSGM: Forward P/S Multiple|Cutera (CUTR) - Forward P/S Multiple|KNW (Know Labs) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Inari Medical (NARI)|Price-to-Projected Revenue Ratio nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical)